We are proud to announce that our MD student Max Szameitat has been awarded the José Carreras Scholarship at this year’s Annual Meeting of the German Society of Hematology and Oncology (DGHO) in Cologne. The prestigious José Carreras Scholarship recognizes outstanding young scientists in the…

We are delighted to announce that Philipp has been awarded the Prize for European HIV Research (ANRS MIE Award for the Best Basic/Translational Paper on HIV) at the European AIDS Conference (EACS 2025) in Paris.

The prize honours his groundbreaking study “Dynamics and durability of HIV‑1…

This summer, we put our teamwork to the test in a city-wide “Schnitzeljagd” through Cologne. Split into teams, we followed cryptic clues, decoded riddles, and discovered just how many scientists it takes to open a locked box (spoiler: more than you’d think). Armed with maps, wild theories, and…

We are pleased to share our latest article, "Current Methods for Detecting and Assessing HIV‑1 Antibody Resistance," published in Frontiers in Immunology. In this work, we summarize key mechanisms by which HIV‑1 escapes broadly neutralizing antibodies and provide an overview of current experimental…

To celebrate the end of a successful (and very busy) year, we took our talents to the neon jungle of Schwarzlicht Minigolf. Think: 3D glasses, glowing obstacles, and scientists attempting “angle of incidence = angle of reflection” in real life. Spoiler: most of us are better at targeting viral…

In July, a group of us swapped the lab bench for the conference stage at the International AIDS Society (IAS) Conference in Munich. Armed with posters, presentations, and caffeine, we shared our latest research on HIV and immune responses with an international crowd. Some of us even sat on panels…

We are pleased to announce another milestone in our research efforts. After collecting large blood draws from 100 HIV-1 infected patients by the beginning of May, by the end of 2023 we reached our goal of enrolling 200 patients in our study. The recruitment of patients and the processing of the…

For the first time our team has investigated the longevity of neutralising antibodies in HIV-1-infected individuals. It is currently believed that an HIV-1 vaccine can only be effective if it induces these antibodies in vaccinated individuals. The findings improve the understanding of the dynamics…

In collaboration with the Bloom lab (Fred Hutchinson Cancer Center, Seattle, USA) we have just published "Mapping the Neutralizing Specificity of Human Anti-HIV Serum by Deep Mutational Scanning." In Cell Host Microbe. In this publication the Bloom lab presents a novel deep mutational scanning…

We are thrilled to announce a significant milestone in our research efforts. Our team has successfully collected over 100 large blood draws from HIV-1 infected patients, marking a crucial step forward in our mission to understand the latent reservoir and HIV-1 antibody resistances in these…

Check out our career options. And maybe you would like to join us?

Full Article on pubmed